Follow on Google News News By Tag Industry News Country(s) Industry News
Follow on Google News | TMNG, NHPR, MRNA, CRWE, SPEX - CRWEWallstreet.com Stock Report! February 15th 2011NHPR has achieved positive earnings for the quarter ended September 30, 2010 compared to a loss of $522,542 for the same period last year. Revenues for the 3rd quarter grew 12.3% over the same period last year.
By: Hanson The Management Network Group, Inc., a management consulting company, provides professional services to the converging communications, media and entertainment industries, and the capital formation firms in the United States, the United Kingdom, and western Europe. These days the uninsured pay back more for care-and acquire less-than those with insurance. But when the uninsured can not pay, health care providers adjust those costs to people who can pay-those who have insurance coverage. Which leads to higher prices for those who buy his or her insurance on the personal market, as well as personnel who get insurance policies for themselves and their families through their job. The need for affordable healthcare alternatives has never been greater. National Health Partners (OTCBB-NHPR.OB) David M. Daniels, President and Chief Executive Officer of National Health Partners, stated: “I am thrilled to announce that we have finally achieved profitability. Due to the fact that our limited medical provider unexpectedly decided to exit the marketplace, we were unable to add any new CARExpress Plus limited medical sales during the 3rd quarter. Yet, despite this temporary setback, we were still able to substantially increase our revenue and reach profitability which is a testament to the underlying strength we have with our core CARExpress health discount programs. Although we achieved positive results in revenues and earnings, we anticipate much better results in 2011.” More about NHPR at: www.nationalhealthpartners.com Marina Biotech, Inc. announced the pricing of an underwritten public offering of 6,375,000 units at a price to the public of $0.80 per unit, for gross proceeds of $5,100,000, before deducting underwriting discounts and commissions and other estimated offering expenses. Each unit consists of one share of common stock and 0.1746 of a warrant to purchase one share of common stock. The warrants are exercisable immediately upon issuance, have a seven-year term and an exercise price of $0.80 per full share. The offering is expected to close on or about February 15, 2011, subject to the satisfaction of customary closing conditions. Marina Biotech, Inc. operates as a biotechnology company that focuses on the development and commercialization of therapeutic products based on RNA interference (RNAi). With the growth of information on the world-wide-web and the amount of time people spend on it, which has in turn generated a new market for web-based advertising. Some of the wealthiest businesses in the world have made sure that they grab their share of the internet marketing pie, and for excellent reasons. Crown Equity Holdings Inc. (OTCBB-CRWE.OB) "In addition to publishing to the mentioned countries, Crown Equity Holdings Inc. has also established online publishing sites for over 660 various cities within those countries," stated Arnulfo Saucedo-Bardan, Chairman of the Board for Crown Equity Holdings Inc. CRWE has also established over 1,100 city specific sites within the US, allowing Crown Equity Holdings Inc. to publish its news and information globally or geographically. More: Hosted IP-PBX gives enterprises of all sizes the most efficient phone system calling features typically offered to only the largest enterprises. No in-house systems or software to purchase, manage and maintain is required for the phone system to function Crown Equity Holdings Inc. (OTCBB-CRWE.OB) The cornerstone of Crown Tele Services Inc. strategy is to meet the highest standards when it comes to delivering VoIP (Voice over Internet Protocol) communication solutions specifically designed to meet the market needs. More about CRWE at: www.crownequityholdings.com Spherix Inc. announced that its President, Dr. Robert Lodder, will be presenting at the 13th Annual BIO CEO & Investor Conference to be held in New York next week. Dr. Lodder will deliver the Company's corporate presentation on Tuesday, February 15, 2011, at 8:00 a.m. in the Conrad Suite of the Waldorf Astoria. Dr. Claire Kruger, Chief Executive Officer, will be accompanying Dr. Lodder. Spherix Incorporated, together with its subsidiaries, operates as a scientific research company. It is developing D-tagatose that is in Phase 3 clinical trial for the treatment of type 2 diabetes. Sign Up For Free Stock Alerts At http://crwewallstreet.com/ ************************************************************ THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEWallStreet publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEWallStreet.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.(Read more at http://crwewallstreet.com/ End
Account Email Address Disclaimer Report Abuse
|
|